Company / Total Assets
Edwards Lifesciences Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$13.7B
FY2025
5-year range
$8.3B / $13.7B
FY2021-FY2025
Trend
+4.9%
vs FY2024
Sector context
#31 of 161
Health Care
What the data says
Edwards Lifesciences's total assets of $13.7B is higher than 81% of companies in the Health Care sector (FY2025). Total Assets has increased for 3 consecutive years, from $8.3B in FY2022 to $13.7B in FY2025.
Based on SEC 10-K filings.
$13.7B in FY2025 with a 5-year CAGR of +13.6%. Top quartile in the Health Care sector.
Improved from $9.4B to $13.7B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +18.2%
- 5-Year CAGR
- +13.6%
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 161This company $13.7B Sector average $14.8B
▼
-7.2% below sector average
Key checks
Key Insights
- Edwards Lifesciences's total assets has grown for 3 consecutive years.
- 5-year CAGR of +13.6%, indicating consistent growth.
- In FY2025, total assets increased 4.9% year-over-year.
- Ranks #31 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.7B | +4.9% |
| FY2024 | $13.1B | +39.4% |
| FY2023 | $9.4B | +12.9% |
| FY2022 | $8.3B | -2.5% |
| FY2021 | $8.5B | +17.5% |
| FY2020 | $7.2B | +11.5% |
| FY2019 | $6.5B | +21.9% |
| FY2018 | $5.3B | -6.0% |
| FY2017 | $5.7B | +25.6% |
| FY2016 | $4.5B | +11.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026